Information Provided By: 
Fly News Breaks for March 15, 2016
AZN
Mar 15, 2016 | 05:36 EDT
Jefferies analyst Jeffrey Holford downgraded AstraZeneca to Hold citing a lack of 2016 catalysts and limited earnings growth visibility. The analyst sees better share performance in 2017 if the pipeline delivers and lowered his price target for the shares to 4,350p from 4,900p.
News For AZN From the Last 2 Days
AZN
Apr 25, 2024 | 05:52 EDT
Consensus $4.56. Backs FY24 revenue view up low double-digit to low teens percentage, consensus $50.95B. Sees FY24 core tax rate 18%-22%.
AZN
Apr 25, 2024 | 05:49 EDT
AZN
Apr 23, 2024 | 11:16 EDT
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 1.72, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 25th.
